Latest Breaking News On - Juliane walz - Page 1 : comparemela.com

Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO

Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesThe netherlandsAnne claude gingrasBruker proteoscapeAlexey nesvizhskiiJuliane walzResearch at sinai healthUs human proteome organization congressVan gool group at radboud universityNetherlands proteomics centerA advancing cancer immunotherapy researchLunenfeld tanenbaum research instituteUniversity of michiganRapid novor incNesvizhskii groupHeck group at utrecht university

Epigenetically acting drugs could support cancer immunotherapy

Epigenetically acting drugs could support cancer immunotherapy
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Christoph plassAashish goyalJuliane walzGerman cancer research centerNature communicationsUniversity hospital

T-cell activator offers protection against coronaviruses in immunocompromised cancer patients

T-cell activator offers protection against coronaviruses in immunocompromised cancer patients
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Frankfurt am mainBeate armbrusterHelmut salihJuliane walzJonass heitmannJonas heitmannUniversity hospital of tuebingenNature communicationsUniversity hospitalMedical facultyInternal medicine

CoVac-1 Induces T-Cell Responses in Patients With B-Cell Deficiencies

CoVac-1, a peptide-based COVID-19 vaccine, induced T-cell responses in patients with B-cell deficiencies.

Claudia tandlerJuliane walzUniversity hospitalCancer therapy advisor

Novel COVID-19 Vaccine for Patients With Blood Cancers

A novel vaccine (CoVac-1) currently in clinical trials in Germany induced T-cell immune responses in a large proportion of patients with blood cancers and B cell deficiencies.

United statesMaria lopezJuliane walzGerman research foundation under germany excellence strategyMinistry of researchSidney kimmel cancer centerWebmd professional networkUniversity hospitalAmerican association for cancer researchJefferson healthMinistry of scienceAmerican associationAna maria lopezFederal ministryGerman research foundationExcellence strategy